AR073360A1 - Proceso para elaborar bivalirudina - Google Patents

Proceso para elaborar bivalirudina

Info

Publication number
AR073360A1
AR073360A1 ARP090103393A ARP090103393A AR073360A1 AR 073360 A1 AR073360 A1 AR 073360A1 AR P090103393 A ARP090103393 A AR P090103393A AR P090103393 A ARP090103393 A AR P090103393A AR 073360 A1 AR073360 A1 AR 073360A1
Authority
AR
Argentina
Prior art keywords
tbu
product
segment
glu
organic solvent
Prior art date
Application number
ARP090103393A
Other languages
English (en)
Inventor
Jin Guo Ding
Tsung Yu Hsiao
Hung Wei Chuang
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of AR073360A1 publication Critical patent/AR073360A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Un proceso para la preparacion de Bivalirudina caracterizado porque comprende los pasos de: a) condensar el segmento AspPheGlu(tBu)Glu(tBu)lleProOBn (S3) y el segmento FmocGlyGlyGIyGlyAsnGlyOH (S2) en un primer solvente orgánico; b) desproteger el producto del paso a); c) condensar el producto del paso b) y el segmento Boc-D-PheProArg(HCI)ProOH (S1) en un segundo solvente orgánico; d) desproteger el grupo bencilo del producto del paso c); e) condensar el producto del paso d) y el segmento Glu(tBu)Glu(tBu)Tyr(tBu)LeuOtBu (S4) en un tercer solvente orgánico; f) desproteger el producto del paso e) para dar Bivalirudina.
ARP090103393A 2008-09-03 2009-09-03 Proceso para elaborar bivalirudina AR073360A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19092808P 2008-09-03 2008-09-03

Publications (1)

Publication Number Publication Date
AR073360A1 true AR073360A1 (es) 2010-11-03

Family

ID=41726391

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090103394A AR073544A1 (es) 2008-09-03 2009-09-03 Proceso para la preparacion de pramlintida
ARP090103393A AR073360A1 (es) 2008-09-03 2009-09-03 Proceso para elaborar bivalirudina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP090103394A AR073544A1 (es) 2008-09-03 2009-09-03 Proceso para la preparacion de pramlintida

Country Status (11)

Country Link
US (2) US8252896B2 (es)
EP (2) EP2334314A4 (es)
JP (2) JP5788321B2 (es)
KR (2) KR20110056536A (es)
CN (2) CN102164608A (es)
AR (2) AR073544A1 (es)
AU (2) AU2009288027B2 (es)
CA (2) CA2736126C (es)
IL (2) IL211556A0 (es)
TW (2) TWI395752B (es)
WO (2) WO2010028122A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
CN101790535A (zh) * 2007-06-29 2010-07-28 隆萨股份公司 制备普兰林肽的方法
EA201101015A1 (ru) * 2008-12-29 2012-02-28 Лонца Брен Са Способ получения бивалирудина
CN102180943A (zh) * 2010-12-16 2011-09-14 深圳市健元医药科技有限公司 一种辅助降血糖多肽药物的生产工艺
WO2013042129A1 (en) 2011-09-23 2013-03-28 Natco Pharma Limited Improved process for preparation of bivalirudin
WO2014032257A1 (zh) * 2012-08-30 2014-03-06 深圳翰宇药业股份有限公司 一种比伐卢定的制备方法
HUE034308T2 (en) 2013-03-21 2018-02-28 Sanofi Aventis Deutschland Preparation of hydantoin-containing peptide products
CA2907521C (en) 2013-03-21 2021-04-13 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
CN104861045A (zh) * 2014-02-20 2015-08-26 复旦大学 环肽化合物gg6f及其制备方法
CN113330021A (zh) * 2019-01-24 2021-08-31 帝斯曼知识产权资产管理有限公司 肽沉淀方法
CN111499719B (zh) * 2020-03-19 2022-04-08 杭州固拓生物科技有限公司 一种合成普兰林肽的方法
CN118530332A (zh) * 2024-07-26 2024-08-23 南京羚诺生物医药技术研究院有限公司 一种普兰林肽的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240913A (en) * 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
WO1992015317A1 (en) 1991-03-08 1992-09-17 Amylin Pharmaceuticals, Inc. Synthetic preparation of amylin and amylin analogues
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
GB9708918D0 (en) 1997-05-01 1997-06-25 Ppl Therapeutics Scotland Ltd Methods
US6821954B2 (en) * 1997-09-18 2004-11-23 Auckland Uniservices Limited Compounds and uses thereof in treating bone disorders
ES2245505T3 (es) * 1998-03-23 2006-01-01 Trimeris Inc. Metodos y composiciones para la sintesis de peptidos (t-20).
US20080108790A1 (en) * 2004-10-16 2008-05-08 Lonza Ag S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis
PT1737889E (pt) * 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
CA2618494A1 (en) * 2005-09-14 2007-03-22 Novetide, Ltd. Process for production of bivalirudin
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
CN101033249B (zh) * 2006-03-10 2011-05-11 周逸明 固相多肽合成比筏芦定的制备方法
EP2057183A2 (en) 2007-03-01 2009-05-13 Novetide Ltd. High purity peptides
CN101790535A (zh) * 2007-06-29 2010-07-28 隆萨股份公司 制备普兰林肽的方法
US20090062511A1 (en) 2007-09-05 2009-03-05 Raghavendracharyulu Venkata Palle Process for the preparation of bivalirudin and its pharmaceutical compositions
EA201101015A1 (ru) * 2008-12-29 2012-02-28 Лонца Брен Са Способ получения бивалирудина

Also Published As

Publication number Publication date
AU2009288036A1 (en) 2010-03-11
KR20110056536A (ko) 2011-05-30
TW201024316A (en) 2010-07-01
CA2736126A1 (en) 2010-03-11
EP2349307B1 (en) 2015-03-04
CA2736113A1 (en) 2010-03-11
JP2012502045A (ja) 2012-01-26
EP2349307A4 (en) 2012-03-21
WO2010028122A8 (en) 2014-11-13
TWI395752B (zh) 2013-05-11
EP2334314A1 (en) 2011-06-22
AU2009288027A2 (en) 2011-11-03
AU2009288027A1 (en) 2010-03-11
WO2010028131A1 (en) 2010-03-11
US8252896B2 (en) 2012-08-28
WO2010028122A1 (en) 2010-03-11
IL211556A0 (en) 2011-05-31
AU2009288027B2 (en) 2014-01-16
KR101634830B1 (ko) 2016-06-29
IL211555A0 (en) 2011-05-31
KR20110069048A (ko) 2011-06-22
EP2334314A4 (en) 2012-03-21
CN102164608A (zh) 2011-08-24
US20100081788A1 (en) 2010-04-01
US20100056755A1 (en) 2010-03-04
AU2009288036A2 (en) 2011-09-08
EP2349307A1 (en) 2011-08-03
TW201014867A (en) 2010-04-16
CA2736126C (en) 2016-11-29
CN102164609A (zh) 2011-08-24
IL211555A (en) 2014-07-31
AR073544A1 (es) 2010-11-17
JP5788321B2 (ja) 2015-09-30
JP2012502044A (ja) 2012-01-26

Similar Documents

Publication Publication Date Title
AR073360A1 (es) Proceso para elaborar bivalirudina
SV2017005589A (es) Nuevos derivados biciclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen
CL2012003428A1 (es) Compuestos derivados de 5,6-dihidro-2h-(1,4)oxazin-3-il amina, inhibidores bace; composición farmacéutica que los comprende; proceso de preparación de la composición; y su uso en el tratamiento del alzheimer, demencia, síndrome de down, entre otras.
WO2017144150A3 (en) Materials for organic electroluminescent devices
CR11853A (es) Proceso y aparato para extraer biodiesel a partir de algas
GB2516798A (en) Conjugated Polymers
BR112014019976A2 (pt) extração de solvente de produtos de algas
ES2655448T3 (es) Revestimientos de componente único curable con humedad a base de polímeros de urea N-sustituidos con cadenas extendidas y alcoxisilanos terminales
BR112017000137A2 (pt) dispositivo de cobertura para um recipiente, em particular para um recipiente de produto cosmético, e um recipiente compreendendo um dispositivo de cobertura desse tipo
BR112016030604B8 (pt) Processo para preparação de ácidos 3- hidroxipicolínicos
MX2019006410A (es) Proceso para secar 1-cloro-3,3,3-trifluoropropeno (hcfo-1233zd).
ES2545458T3 (es) Fragmentos de PTEC
ATE537139T1 (de) Verfahren zur herstellung von n,n- dimethylaminoethoxyethanol
TW201612127A (en) Glass substrate with antistatic film and method for manufacturing glass substrate with antistatic film
TH177981A (th) กระบวนการสำหรับการเตรียมกรด 3-ไฮดรอกซิพิโคลินิค
TH130445B (th) กระบวนการสำหรับการผลิตโพลีเมอร์ที่ปราศจากน้ำและตัวทำละลาย
TH159735S (th) ขาตั้งรถจักรยาน
TH179133A (th) คอมพอสิตระดับนาโนเมตรที่มีพื้นที่ผิวจำเพาะสูงจากยางธรรมชาติและซิลิกา และกรรมวิธีการเตรียม
TH168459A (th) สารประกอบใหม่สำหรับการรักษาภาวะน้ำตาลในเลือดต่ำอย่างรุนเเรง
TH114642B (th) กระบวนการสำหรับการผลิตของโพลีเมอร์ที่ปราศจากน้ำ และ ตัวทำละลาย
TH178401A (th) กระบวนการสำหรับการเตรียมคาร์บาโซล
TH171381A (th) กรรมวิธีสำหรับการผลิต แอรอแมทิคไวนิล/คอนจุเกเทดไดอีนโคพอลิเมอร์ และผลิตภัณฑ์ของไฮโดรจีเนชันของสิ่งนั้น
TH150372S (th) ขาตั้งอ่าง
MX2015014942A (es) Proceso de sintesis de ambrox a partir de 13,14,15,16,-tetranor-8a ,12-labdanodiol.
TH174478A (th) กระบวนการสำหรับการเตรียมตัวเร่งปฏิกิริยาสำหรับการผลิตอะโรมาติกคาร์บอเนต

Legal Events

Date Code Title Description
FB Suspension of granting procedure